Clinical Trial Update: Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks [Phase 3]

View source ↗

Summary

Phase 3 trial of Treximet (sumatriptan/naproxen sodium) for the acute treatment of multiple migraine attacks has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders, Migraine | Phase 3 | Status: COMPLETED